Cambridge Oncology Seminar Series

Torn newspaper headlines with the words cancer, health and medicine positioned with a stethoscopeThis seminar series covers clinical, laboratory and translational aspects of cancer. It is jointly organised by researchers at the Cambridge Research Institute, the Addenbrooke's Hospital Clinical, Medical and Surgical Oncology departments and the Hutchison/MRC Research Centre.

The talks are open to all interested persons from the University of Cambridge, Cancer Research UK and Addenbrooke's Hospital. Members of the local pharma and biotechnology companies are also welcome to attend by prior arrangement with Laura Blackburn.

All talks take place on Tuesdays at 12 noon in the Sackler Lecture Theatre (Level 7, CIMR), the Max Perutz Lecture Theatre (MRC-LMB), or in the Cambridge Research Institute Lecture Theatre.

Seminars 2011-2012

Transcriptional control of EMT and malignant tumor progression

12:00pm, 7 February 2012
Location: Sackler Lecture Theatre, Level 7, CIMR

Speaker: Gerhard Christofori, University of Basel (Hutchison/MRC Research Centre Seminar)

 

Radiotherapy toxicity, radiogenomics and RAPPER

12:00pm, 14 February 2012
Location: CRI Lecture Theatre

Speaker: Gill Barnett, Department of Oncology

 

Myeloproliferative neoplasms - JAK/STAT signalling and stem cell subversion

12:00pm, 21 February 2012
Location: CRI Lecture Theatre

Speaker: Tony Green (Department of Haematology, University of Cambridge)

 

DICER1 and miRNA processing - a novel paradigm in cancer predisposition

12:00pm, 28 February 2012
Location: CRI Lecture Theatre

Speaker: Marc Tischkowitz, Department of Medical Genetics

 

Commissioning in the NHS

12:00pm, 13 March 2012
Location: CRI Lecture Theatre

Speaker: Hannah Farrar, Director of Strategy and System Management, NHS London

 

Exploiting ASS1 deficiency in the treatment of mesothelioma

11:30am, 27 March 2012
Location: Seminar room 2, Clinical School, Addenbrooke's Hospital

Speaker: Peter Szlosarek, Barts and The London

 

Economics of cancer medicines

12:00pm, 24 April 2012
Location: CRI Lecture Theatre

Speaker: Richard Sullivan, King's College London 

 

Lung cancer and phase 1 clinical trials

5:00pm, 3 May 2012
Location: CRI Lecture Theatre

Speaker: Ross Camidge, University of Colorado Hospital and University of Colorado Cancer Centre

Note unusual time and day

 

Title to be confirmed

12:00pm, 5 June 2012
Location: Sackler Lecture Theatre, Level 7, CIMR

Speaker: Sibylle Mittnacht, UCL Cancer Institute

Hutchison/MRC Research Centre Seminar

 

Pancreatic cancer

12:00pm, 12 June 2012
Location: CRI Lecture Theatre

Speaker: Thorsten Hagemann, Barts Cancer Institute

 

Title to be confirmed

5:00pm, 21 June 2012
Location: CRI Lecture Theatre

Speaker: Keith Flaherty, Massachusetts General Hospital

Note unusual day and time